The Race to Prepare for Medicare’s New Drug Pricing Powers

<p>The Inflation Reduction Act gives Medicare historic new powers to control prescription drug prices. We go inside the government’s race to implement these new powers — and the pharmaceutical industry’s efforts to blunt their impact.</p><br><p>Guests:</p><p>Alice Valder Curran, JD, Partner, Hogan Lovells</p><p>Sean Dickson, JD, MPH, Director of Health Policy, West Health Policy Center</p><p>Amber Jessup, PhD, Chief Economist, Office of Inspector General, Department of Health and Human Services</p><p>Mark Newsom, Founder and Principal, Health Evaluations</p><br><p>Learn more and read a full transcript on <a href="https://tradeoffs.org/2022/09/08/inflation-reduction-act-drug-prices/" rel="noopener noreferrer" target="_blank">our website</a>.</p><br><p>Want more Tradeoffs? Sign up for our free <a href="https://tradeoffs.us3.list-manage.com/subscribe?u=6ab1fc39a0b1b15521551487c&amp;id=89c5edcb93&amp;utm_source=twitter-newsletter-signup&amp;utm_medium=twitter" rel="noopener noreferrer" target="_blank">weekly newsletter</a> featuring the latest health policy research and news.</p><br><p>Support this type of journalism today, <a href="https://tradeoffs.org/donate" rel="noopener noreferrer" target="_blank">with a gift</a>.</p><br><p>Follow us on <a href="https://twitter.com/tradeoffspod" rel="noopener noreferrer" target="_blank">Twitter</a>.&nbsp;</p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>